Human Laboratory Study of Varenicline for Alcohol Use Disorder

What is the purpose of this trial?

This study is a double-blind, randomized, placebo-controlled, parallel group, two-site study designed to assess the effects of varenicline as compared with placebo on responses to in vivo alcohol cue exposure in the human laboratory setting.


Participation Guidelines

Ages: 21 years and older

Gender: Both


National Institute on Alcohol Abuse and Alcoholism

Dates: 05/15/2017 - 11/30/2017

Last Updated: 05/24/2017

Study HIC#: 1611018672

Get Involved

For more information about this study, contact:
Thomas B Liss
+1 203-974-7555
thomas.liss@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Stephanie Samples O'Malley

Principal Investigator

Sub-Investigators